What Are Oocytes and How Do They Affect Fertility?

Oocytes are the egg cells produced by the ovaries, and their quantity and quality are among the most important biological factors determining whether a pregnancy can occur. Unlike sperm, which are produced continuously throughout a man’s life, a woman’s oocytes are established before she is even born and dwindle from that point forward. This fixed supply, combined with the fact that each oocyte must carry enough molecular machinery to fuel the earliest stages of embryo development, makes oocyte biology central to nearly every conversation about fertility.

How Oocytes Form Before Birth

The cells that will eventually become oocytes start out as primordial germ cells in the developing fetus. These cells multiply rapidly, then enter the early stages of cell division and pause. By roughly the time of birth, the oocytes have reached a specific resting phase of their first division and will stay suspended there for years or even decades until a hormonal signal tells them to continue.

This pause is not accidental. Oocytes arrest at a stage called the diplotene (or dictyate) phase after passing through several earlier steps of their initial division in the fetal ovary.¹ That long suspension means the oocytes you ovulate in your twenties or thirties have been sitting in a paused state since before you were born. The length of that pause turns out to matter a great deal, because cellular structures can deteriorate over time.

Waking Up an Oocyte

Each month during the reproductive years, a surge of luteinizing hormone (LH) kicks a mature follicle into action. Inside that follicle sits an oocyte that has been waiting in its arrested state. The LH signal lowers levels of certain signaling molecules inside the follicle, which in turn activates the internal machinery the oocyte needs to finally complete its stalled division.² The oocyte finishes the first round of division, casts off a small packet of extra chromosomes called the first polar body, and then pauses again at a second stage of division. Only if a sperm arrives will it complete that final step.

This two-stage pause-and-resume design means an oocyte gets two chances for things to go right or wrong with chromosome sorting, and the hormonal environment surrounding it at each step can influence the outcome.

What Happens at Fertilization

When a sperm penetrates an oocyte, the egg needs to do more than simply merge its chromosomes with the sperm’s. It triggers a rapid release of small packets called cortical granules, which dump their contents into the narrow space just outside the oocyte’s membrane. This reaction modifies the outer shell of the egg so that no additional sperm can enter, a process that prevents the embryo from ending up with too many sets of chromosomes.³ An oocyte that cannot mount this block properly risks a fertilization failure or an abnormal embryo.

Beyond that immediate defense, the oocyte supplies virtually all of the early embryo’s starting materials. The sperm contributes DNA and not much else. Everything the embryo needs to survive its first few days of cell division, before its own genes switch on, comes from molecules stockpiled in the oocyte during its long growth phase. Stored messenger RNAs and proteins drive those early divisions, and if these maternal stores are insufficient or degraded, the embryo stalls.⁴ This is why fertility specialists talk so much about “oocyte quality” rather than just whether ovulation happens at all.

Why Mitochondria Are the Oocyte’s Engine

Oocytes are the largest cells in the human body, and they demand enormous amounts of energy. The power plants responsible for that energy are mitochondria, and a mature oocyte contains far more of them than a typical body cell. During maturation, the number of mitochondrial DNA copies climbs sharply and the mitochondria redistribute themselves within the cell to meet the energy demands of ongoing gene activity and protein production.⁵ There is a direct correlation between how much energy an oocyte can produce and how likely it is to develop successfully after fertilization.

Animal studies help illustrate the point. When researchers chemically reduced mitochondrial energy output in pig oocytes, maturation rates dropped and fewer embryos reached the blastocyst stage.⁶ Mitochondria are not just passive batteries; their function shapes whether an oocyte can complete its division correctly and whether the resulting embryo can keep dividing.

The Age Factor and Chromosome Errors

The single biggest influence on oocyte quality is the age of the person carrying them. As oocytes sit in their years-long arrested state, the protein structures that hold paired chromosomes together gradually weaken. This deterioration of a molecular glue called cohesin is now considered a leading explanation for why chromosome-sorting errors rise steeply with age.⁷ When chromosomes are not held together tightly enough, they can separate unevenly, producing an egg with too many or too few chromosomes. An embryo that develops from such an egg is aneuploid, and aneuploidy is the most common genetic cause of miscarriage and failed implantation.

Cohesin breakdown is not the only culprit. Researchers have identified several overlapping mechanisms behind age-related aneuploidy, including problems with the cell’s quality-control checkpoint for chromosome sorting, changes to how DNA-packaging proteins are chemically modified, and declining mitochondrial function within the oocyte itself.⁸ These factors reinforce each other: an older oocyte has less energy, weaker structural scaffolding, and a less reliable error-detection system all at once.

Ovarian Reserve and What Testing Tells You

Ovarian reserve refers to the number of remaining oocytes that could potentially yield a pregnancy.⁹ Blood tests for anti-Müllerian hormone (AMH) and ultrasound counts of small follicles visible on the ovaries are the most commonly used estimates. These tests do a reasonable job of predicting how many eggs a person might produce during an IVF cycle, but they are frequently misunderstood as measures of overall fertility. A low AMH tells you the pool of remaining oocytes is smaller than average for your age; it does not necessarily mean you cannot conceive naturally. Conversely, a high AMH does not guarantee the eggs you have are chromosomally normal.

The distinction between quantity and quality matters because the two decline on different timelines. The total number of oocytes drops steadily from birth onward, but the rate of chromosomal errors in remaining oocytes accelerates more sharply after the mid-thirties. This is why someone in their late thirties with a reassuringly normal AMH level can still face higher miscarriage rates than someone younger with lower numbers.

Oxidative Stress, Weight, and Lifestyle

Oocytes are vulnerable to oxidative stress, the buildup of reactive molecules that can damage DNA, shorten protective chromosome caps, impair mitochondria, and increase the odds of sorting errors during division.¹⁰ Several common lifestyle and medical factors push oxidative stress higher, including smoking, exposure to environmental pollutants, and chronic inflammation.

Body weight also plays a role. Obesity disrupts the balance of fats in the fluid surrounding the developing follicle, creating a toxic environment for the oocyte. This lipotoxicity damages mitochondria and the cell’s internal recycling system, leaving the oocyte short on energy at the exact moment it needs the most.¹¹ Laboratory studies have shown that exposing oocytes to elevated fatty acids completely shuts down one of their energy-production pathways.¹²

Environmental Chemicals and Oocyte Health

Bisphenol A (BPA), a chemical found in many plastics and food-container linings, has drawn particular attention for its effects on oocytes. Studies across mice, pigs, and human cells have found that BPA disrupts the spindle, the structure that physically pulls chromosomes apart during division, and delays the completion of that division. BPA exposure has also been linked to mitochondrial dysfunction, accumulation of reactive oxygen species, and impaired connections between the oocyte and its surrounding support cells.¹³

Manufacturers have responded to BPA concerns by introducing alternatives like BPF and BPS, but a scoping review found that these substitutes are not necessarily safer for oocytes. The vast majority of lab-based exposure studies, over 94% for BPA alternatives, reported at least one harmful effect on oocyte health, including abnormal spindle formation and increased arrest during division.¹⁴ The practical implication is that switching to “BPA-free” products does not automatically eliminate the risk.

Chemotherapy and the Ovarian Reserve

Certain cancer treatments pose a direct threat to oocytes. Drugs like cyclophosphamide and doxorubicin can cause rapid DNA damage in the oocytes of resting follicles, triggering cell death within hours. Studies have shown that massive loss of the ovarian reserve can follow a single acute exposure to these agents.¹⁵ Chemotherapy also damages the blood supply and supporting tissue of the ovary, creating additional indirect harm to follicles that survived the initial assault.¹⁶

This is why oncologists now routinely discuss fertility preservation before starting treatment in reproductive-age patients. Egg or embryo freezing before chemotherapy begins is the most established option, though research into drugs that might protect dormant follicles during treatment is ongoing.

Freezing Oocytes and How Technique Matters

Oocyte cryopreservation, commonly called egg freezing, has become a mainstream fertility-preservation strategy. Two methods have been used: traditional slow freezing and a newer rapid-cooling approach called vitrification. Vitrification has largely replaced slow freezing because it produces better outcomes at nearly every step. In a randomized trial, oocyte survival after thawing was around 81% with vitrification compared to 67% with slow freezing, and clinical pregnancy rates from vitrified eggs were roughly three times higher.¹⁷

The advantage appears to come down to ice crystal formation. Slow freezing gives water molecules more time to crystallize, which can puncture delicate internal structures. Vitrification cools so quickly that the fluid solidifies into a glass-like state without forming crystals. Microscopic analysis confirms that vitrified oocytes show fewer internal vacuoles and better overall structural preservation.¹⁸ A meta-analysis of embryo cryopreservation reinforced the pattern, showing vitrification produced significantly better survival rates for embryos as well.¹⁹

In Vitro Maturation and Its Limits

Sometimes during an IVF cycle, not all retrieved oocytes are fully mature. Clinics can attempt to mature these immature oocytes in the lab, a process called rescue in vitro maturation (IVM). While these oocytes can reach the stage needed for fertilization, their developmental potential is noticeably lower. A meta-analysis across 24 studies found that oocytes matured through rescue IVM had significantly reduced fertilization rates, cleavage rates, and clinical pregnancy rates compared to eggs that matured inside the body.²⁰

The gap likely exists because oocytes need more than just the right hormonal cues. They also need to have reached a certain physical size and accumulated specific proteins during their growth phase inside the follicle. Research suggests the minimum follicle diameter for developmental competence in humans is roughly 5 to 7 millimeters, and oocytes pulled from smaller follicles tend to lack key proteins needed for normal development even if they appear mature under the microscope.²¹ One encouraging finding from the meta-analysis is that when rescue-IVM oocytes do produce blastocysts that test as chromosomally normal, live-birth rates after transfer are comparable to those from in-vivo-matured eggs, suggesting the surviving embryos are not inherently defective.

Reading Oocyte Quality Without Breaking the Egg

One persistent challenge in IVF is that you cannot directly examine what is happening inside an oocyte without destroying it. Researchers have found a workaround by studying the cumulus cells, the cluster of support cells that surround each oocyte inside its follicle. These cells communicate constantly with the oocyte through tiny channels, exchanging nutrients, signaling molecules, and metabolic waste. Because of this close relationship, the gene activity patterns in cumulus cells mirror the health of the oocyte they surround.²² Profiling which genes are turned up or down in these cells offers a non-invasive window into oocyte and embryo quality.²³

This approach is still largely a research tool rather than a routine clinical test, but it highlights a broader point: oocyte quality is not determined solely by the egg itself. The entire follicular neighborhood, including the fluid it bathes in, the cells that nourish it, and even the blood supply to that patch of ovary, contributes to whether the oocyte is competent to become an embryo.

Epigenetic Programming in Oocytes

Beyond the DNA sequence itself, oocytes carry a layer of chemical tags on their DNA and on the proteins that package it. These epigenetic marks help control which genes will be active or silent during early embryo development. Research in mice has shown that a specific set of these marks is established around the time of birth, right when oocytes are settling into their long arrest phase, and that this programming step is essential for forming a functional ovarian reserve.²⁴

Histone modifications, another form of epigenetic regulation, change dynamically during oocyte growth and maturation and continue to be important through the first few cell divisions of the embryo.²⁵ This means that environmental exposures or metabolic disruptions during the growth of an oocyte could leave marks that affect the embryo even if the DNA itself is intact. The field is young, and most of the evidence comes from animal models, but it adds another dimension to why conditions during oocyte development matter for outcomes well beyond fertilization.

Circadian Rhythm and Oocyte Quality

An unexpected line of research has connected disrupted sleep-wake cycles to oocyte health. In a mouse study, animals exposed to constant light, which scrambles their internal clock, produced oocytes with abnormal spindle structures, the same apparatus responsible for chromosome separation during division. When researchers treated those oocytes with a compound that reactivated a specific signaling pathway, normal spindle shape was restored.²⁶ The finding is early-stage and based on an animal model, but it raises questions about whether shift work, jet lag, or chronic sleep disruption could subtly impair oocyte quality in people, an area where human data are still limited.

Can the Ovary Make New Eggs?

For more than a century, the dogma has been that women are born with all the eggs they will ever have. That view was challenged in the 2000s when several research groups reported finding cells in adult mammalian ovaries that appeared to divide and produce new oocyte-like cells. These so-called oogonial stem cells have been identified in ovaries from mice and humans, and some experiments in animals have shown they can generate functional eggs, embryos, and even offspring after transplantation.²⁷

The field remains controversial. Other labs have struggled to replicate some of the key findings, and whether these cells contribute meaningfully to natural fertility in humans is still debated. If the concept holds up, it could eventually open paths to therapies for people with diminished ovarian reserve, including cancer survivors. For now, the clinical reality has not changed: fertility planning still needs to account for a finite and declining egg supply.

Mitochondrial Replacement and Experimental Frontiers

Because mitochondria are inherited almost entirely from the oocyte, defects in mitochondrial DNA can be passed from mother to child. Techniques collectively known as mitochondrial replacement therapy aim to prevent this by transferring the nuclear DNA from an affected oocyte into a donor egg whose mitochondria are healthy, effectively giving the resulting embryo three genetic contributors. Early clinical applications of maternal spindle transfer and pronuclear transfer have demonstrated that this approach can prevent carryover of harmful mitochondrial mutations.²⁸ The technique is legal in the United Kingdom under strict regulation but remains prohibited or unregulated in most other countries, in part because of ethical questions about germline modification and the “three-parent” framing that has surrounded the procedure in public discourse.